Inventor · disambiguated record
Jeffrey R. Crosby
Also filed as: CROSBY JEFFREY R
9 granted patents·14 pending applications·30 citations·filing 2005–2023
83Inventor score
Files withIONIS PHARMACEUTICALS INC10FREIER SUSAN M3ISIS PHARMACEUTICALS INC3KARRAS JAMES G3MONIA BRETT P2
Top patents by PatentIndex Score
23 records- 0194US8334372B2Modulation of factor 11 expressionFREIER SUSAN M·Filed 2009·Granted Dec 18, 2012·21 cites·57 claims
- 0284US10961271B2Methods of modulating KEAP1IONIS PHARMACEUTICALS INC·Filed 2017·Granted Mar 30, 2021·2 cites·40 claims
- 0384US8735370B2Modulation of factor 11 expressionISIS PHARMACEUTICALS INC·Filed 2012·Granted May 27, 2014·4 cites·30 claims
- 0484US2023263822A1Modulation of factor 11 expressionIONIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0577US2024327838A1MODULATORS OF ENaC EXPRESSIONIONIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0674US11376273B2Modulation of factor 11 expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Jul 5, 2022·0 cites·20 claims
- 0774US8765700B2Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditionsTACHAS GEORGE·Filed 2005·Granted Jul 1, 2014·2 cites·14 claims
- 0872US9150864B2Methods for modulating factor 12 expressionMONIA BRETT P·Filed 2011·Granted Oct 6, 2015·1 cites·21 claims
- 0967US2022290137A1Compounds and methods for reducing spdef expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1064US12018261B2Compounds and methods for modulating factor XIIIONIS PHARMACEUTICALS INC·Filed 2021·Granted Jun 25, 2024·0 cites·58 claims
- 1162US2021139906A1Compounds and methods for reducing spdef expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1261US2010202977A9Modulation of Stat 6 Expression for the Treatment of Airway HyperresponsivenessKARRAS JAMES·Filed 2006·Application pending·0 cites
- 1361US2013190384A1Modulation of factor 11 expressionISIS PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 1460US2024294920A1Modulation of nox4 expressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1559US2017035798A1Modulation of factor 11 expressionIONIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1657US8153603B2Compositions and their uses directed to IL-4R alphaKARRAS JAMES G·Filed 2006·Granted Apr 10, 2012·0 cites·20 claims
- 1755US2021180057A1MODULATORS OF ENaC EXPRESSIONIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1854US2012316221A1Compositions and their uses directed to il-4r alphaKARRAS JAMES G·Filed 2012·Application pending·0 cites
- 1953US2006258610A1Modulation of STAT 6 expression for the treatment of airway hyperresponsivenessISIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2051US9029337B2Modulation of factor 7 expressionFREIER SUSAN M·Filed 2008·Granted May 12, 2015·0 cites·27 claims
- 2146US2007270366A1Double stranded nucleic acid molecules targeted to il-4 receptor alphaKARRAS JAMES G·Filed 2006·Application pending·0 cites
- 2239US2012214862A1Modulation of factor 7 expressionFREIER SUSAN M·Filed 2010·Application pending·0 cites
- 2335US2012083522A1Modulation of inflammatory responses by factor xiMONIA BRETT P·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey R. Crosby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →